Pyng enhanced infusion system
This article was originally published in Clinica
The US FDA has awarded special 510(k) clearance to Canadian firm Pyng Medical, allowing the sale of an improved version of the FAST1 intraosseous infusion system. Vancouver-based Pyng claims that the device is the most rapid, reliable and safe alternative to IV infusion, and provides lifesaving vascular access for fluid and drug resuscitation in shock and trauma victims. The improved system has an infusion tube that no longer requires the use of a removal tool; Pyng said that the improvements reflect feedback from key customers based on real-life applications in the battlefield and emergency environments. The product will be launched in the US immediately.
You may also be interested in...
Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.
Mylan’s full year 2019 earnings report was its last as an independent company, so the focus was on the coming merger with Pfizer’s Upjohn and growth prospects for the new company, Viatris.
Colgate Zero toothpastes and mouthwashes promote what’s missing; Tom’s of Maine natural personal care expands with prebiotic toothpaste, deodorant and hand soap; Gaia adds hemp to its herbs; and Church & Dwight goes environmentally friendly with VitaFusion Goodness supplements, adds CBD versions to line, too.